The CNN (2/7, Young) "The Chart" blog reported that "cardiac resynchronization therapy with defibrillator (CRT-D), a treatment designed to prevent sudden cardiac death by using a defibrillator to shock the heart back into rhythm, provided a significant benefit to women over men," according to a study published in the Journal of the American College of Cardiology.
HealthDay (2/7, Preidt) reported that investigators "looked at the effectiveness of cardiac resynchronization therapy with defibrillator (CRT-D) in 1,820 patients in Canada."
WebMD (2/7, Mann) reported that "women in the study who received this therapy had a 70% reduction in heart failure events and a 72% reduced risk of dying from any cause. By contrast, men showed a 35% reduction of heart failure events, the study shows."
Reuters (2/8, Steenhuysen) quotes Dr. Arthur Moss, one of the study's authors, as saying, "Our finding was unexpected, but extremely important because this is the only heart treatment that is clearly better in women than men." AFP (2/8) also covers the story.
POSTED BY STEVEN ALMANY, MD